Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ayalew Tefferi

Showing results (11-20 of 910) with videos related to

Pageof 91
Sort By:
Acta Haematologica|June 21, 2008
Mutant molecules of interest in myeloproliferative neoplasms: introductionAyalew Tefferi
Mayo Clinic Proceedings|July 13, 2004
Practical algorithms in anemia diagnosisAyalew Tefferi
Mayo Clinic Proceedings|November 3, 2007
Pharmaceutical erythropoietin use in patients with cancer: is it time to abandon ship or just drop anchor?Ayalew Tefferi
Seminars in Cardiothoracic and Vascular Anesthesia|January 4, 2007
Genomics basics: DNA structure, gene expression, cloning, genetic mapping, and molecular testsAyalew Tefferi
Leukemia & Lymphoma|December 5, 2008
Epigenetic alterations and anti-epigenetic therapy in myelofibrosisAyalew Tefferi
American Journal of Hematology|February 26, 2011
Annual Clinical Updates in Hematological Malignancies: a continuing medical education series: polycythemia vera and essential thrombocythemia: 2011 update on diagnosis, risk-stratification, and managementAyalew Tefferi
Blood|August 17, 2013
Ruxolitinib targets DCs: for better or worse?Ayalew Tefferi
Leukemia Research|August 25, 2012
Myeloproliferative neoplasms 2012: the John M. Bennett 80th birthday anniversary lectureAyalew Tefferi
Cancer|January 7, 2011
Second-generation tyrosine kinase inhibitors in chronic myelogenous leukemia: before or after imatinib?Ayalew Tefferi
Current Hematologic Malignancy Reports|April 29, 2010
A refined diagnostic algorithm for polycythemia vera that incorporates mutation screening for JAK2(V617F)Ayalew Tefferi
Pageof 91

Showing results (11-20 of 910) with videos related to

Sort By:
Pageof 91
Acta Haematologica|June 21, 2008
Mutant molecules of interest in myeloproliferative neoplasms: introductionAyalew Tefferi
Mayo Clinic Proceedings|July 13, 2004
Practical algorithms in anemia diagnosisAyalew Tefferi
Mayo Clinic Proceedings|November 3, 2007
Pharmaceutical erythropoietin use in patients with cancer: is it time to abandon ship or just drop anchor?Ayalew Tefferi
Seminars in Cardiothoracic and Vascular Anesthesia|January 4, 2007
Genomics basics: DNA structure, gene expression, cloning, genetic mapping, and molecular testsAyalew Tefferi
Leukemia & Lymphoma|December 5, 2008
Epigenetic alterations and anti-epigenetic therapy in myelofibrosisAyalew Tefferi
American Journal of Hematology|February 26, 2011
Annual Clinical Updates in Hematological Malignancies: a continuing medical education series: polycythemia vera and essential thrombocythemia: 2011 update on diagnosis, risk-stratification, and managementAyalew Tefferi
Blood|August 17, 2013
Ruxolitinib targets DCs: for better or worse?Ayalew Tefferi
Leukemia Research|August 25, 2012
Myeloproliferative neoplasms 2012: the John M. Bennett 80th birthday anniversary lectureAyalew Tefferi
Cancer|January 7, 2011
Second-generation tyrosine kinase inhibitors in chronic myelogenous leukemia: before or after imatinib?Ayalew Tefferi
Current Hematologic Malignancy Reports|April 29, 2010
A refined diagnostic algorithm for polycythemia vera that incorporates mutation screening for JAK2(V617F)Ayalew Tefferi
Pageof 91